Charles J. Scimeca
Vorstandsvorsitzender bei REJUVEL BIO-SCIENCES, INC.
Profil
Charles J.
Scimeca is the founder of Rejuvel Bio-Sciences, Inc. (founded in 2009) where he holds the title of Chief Executive Officer.
He is currently the President, Secretary & Director at Nueearth, Inc. and Renuell International, Inc. Mr. Scimeca's former positions include President & Chief Executive Officer at Coast to Coast Equity Group, Inc., Principal at Worldwide Biotech & Pharmaceutical Co., and President at Coast To Coast Realty Group.
Aktive Positionen von Charles J. Scimeca
Unternehmen | Position | Beginn |
---|---|---|
REJUVEL BIO-SCIENCES, INC. | Vorstandsvorsitzender | - |
Nueearth, Inc. | Präsident | - |
Renuell International, Inc. | Präsident | - |
Ehemalige bekannte Positionen von Charles J. Scimeca
Unternehmen | Position | Ende |
---|---|---|
Coast to Coast Equity Group, Inc. | Vorstandsvorsitzender | - |
Coast To Coast Realty Group | Präsident | - |
Worldwide Biotech & Pharmaceutical Co.
Worldwide Biotech & Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Worldwide Biotech and Pharmaceutical Corp. develops, manufactures, and markets pharmaceuticals. Through its subsidiaries, it engages in the research and development, manufacture and distribution of in vitro diagnostics, human vaccine, biomedicines, traditional Chinese medicines, synthetic medicines and medical devices with frontier technologies. The company was founded in 1961 and is headquartered in Xi'an, China. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
REJUVEL BIO-SCIENCES, INC. | Finance |
Private Unternehmen | 5 |
---|---|
Worldwide Biotech & Pharmaceutical Co.
Worldwide Biotech & Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Worldwide Biotech and Pharmaceutical Corp. develops, manufactures, and markets pharmaceuticals. Through its subsidiaries, it engages in the research and development, manufacture and distribution of in vitro diagnostics, human vaccine, biomedicines, traditional Chinese medicines, synthetic medicines and medical devices with frontier technologies. The company was founded in 1961 and is headquartered in Xi'an, China. | Health Technology |
Coast to Coast Equity Group, Inc. | |
Nueearth, Inc. | |
Renuell International, Inc. | |
Coast To Coast Realty Group |